31 results
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Vasopressors Table ... Internet Book of Critical ... #Properties #Table ... #Pharmacology # ... Effect #Management
Shock and Vasoactive Drugs 
1) Determine type and etiology of shock
 • Distributive: Sepsis, Anaphylaxis, Neurogenic
rupture, VSD, etc ... vasoactive drug pharmacology ... hasankazmi01 #Vasopressors ... inopressors #diagnosis #management ... #comparison #table
Coverage of common antibiotics used in the hospital

For empiric coverage, first define the type of infection,
define the type of infection ... ESBL, KPC, VRE. etc ... ampicillin #management ... #antibiogram #pharmacology ... #table #sensitivities
Vasopressors and Inotropes
 • Norepinephrine - Levophed - "Levo" - Generally thought of as the first
Vasopressors and ... of shock, HOCM, etc ... #Inotropes #management ... summary #comparison #table ... #pharmacology #
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Clinical Disease ... clinical manifestation ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Treatment of COVID-19 Infection ... or detachment, etc ... highlighted circle= clinical ... Treatment #COVID19 #Pharmacology ... #Table #Management
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
will vary with clinical ... No pharmacologic ... be effective in preventing ... be effective in preventing ... CriticalCare #diagnosis #management
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
interrupted schedule (e.g ... Leishmaniasis #Prevention ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
chew, or crush tablet ... mucosal #IDSA #Prevention ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
Cytomegalovirus Infections ... in HIV-AIDS Preventing ... other factors (e.g ... #Treatment #management ... #HIVAIDS #pharmacology